Is salt craving more suggestive of primary or secondary adrenal insufficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Salt Craving in Adrenal Insufficiency: Primary vs Secondary

Salt craving is more suggestive of primary adrenal insufficiency rather than secondary adrenal insufficiency, as it indicates mineralocorticoid deficiency which is characteristic of primary adrenal insufficiency. 1

Pathophysiological Basis

  • In primary adrenal insufficiency (PAI), there is destruction or dysfunction of the adrenal cortex, leading to deficiency of all adrenocortical hormones including mineralocorticoids (aldosterone) 2
  • Secondary adrenal insufficiency results from pituitary dysfunction affecting ACTH production, which primarily impacts cortisol production while preserving aldosterone secretion (as aldosterone is mainly regulated by the renin-angiotensin system) 2
  • Salt craving occurs due to mineralocorticoid deficiency, which causes sodium loss and disruption of electrolyte balance 1, 3

Clinical Differentiation

Primary Adrenal Insufficiency Features:

  • Salt craving is a characteristic symptom due to aldosterone deficiency 1
  • Patients are advised to eat sodium salt and salty foods without restriction as part of treatment 1
  • Other associated findings include:
    • Hyperpigmentation (due to elevated ACTH) 4
    • Hyperkalemia 5
    • Hyponatremia 5
    • Postural hypotension 1

Secondary Adrenal Insufficiency Features:

  • Typically lacks salt craving as mineralocorticoid production remains largely intact 2
  • No hyperpigmentation (ACTH is low) 2
  • Less severe or absent electrolyte disturbances 2
  • May still have fatigue, weakness, and glucocorticoid deficiency symptoms 6

Diagnostic Implications

  • The presence of salt craving should prompt evaluation for primary adrenal insufficiency 1, 5
  • Mineralocorticoid replacement is evaluated clinically by asking patients about salt cravings, measuring blood pressure in supine and standing positions, and identifying peripheral edema 1
  • Under-replacement of mineralocorticoids is common and sometimes compensated for by over-replacement of glucocorticoids 1, 3

Treatment Considerations

  • Patients with primary adrenal insufficiency require both glucocorticoid and mineralocorticoid replacement 7, 8
  • Most patients with primary adrenal insufficiency should take 50–200 μg fludrocortisone as a single daily dose 9
  • Allowing unrestricted sodium intake and avoiding salt craving is an important component of substitution therapy 1
  • Mineralocorticoid replacement is not typically required in secondary adrenal insufficiency 2

Clinical Pearls

  • Salt craving can be used as a clinical indicator to monitor adequacy of mineralocorticoid replacement in primary adrenal insufficiency 9
  • Persistent salt craving despite adequate sodium intake may indicate the need for increased fludrocortisone dose 9
  • Patients should avoid potassium-containing salts which are often marketed as "healthy" 1
  • Avoid liquorice and grapefruit juice as they potentiate the mineralocorticoid effect of hydrocortisone 9

Remember that salt craving is a valuable diagnostic clue that helps distinguish primary from secondary adrenal insufficiency and guides appropriate replacement therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy.

The Journal of clinical endocrinology and metabolism, 2018

Research

Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.

Best practice & research. Clinical endocrinology & metabolism, 2015

Research

Adrenal insufficiency.

Lancet (London, England), 2021

Guideline

Combination Therapy for Adrenal Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Adjusting Fludrocortisone Dose in Adult Adrenal Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.